TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback